Missions

AlzProtect is a start-up company created in 2008 developing proprietary anti- Alzheimer drugs acting through an original mechanism of action and discovered in a collaborative work of several years at INSERM (Institut National de la Santé et de la Recherche Médicale) and the University of Lille 2.

The objective of the company is to bring its first drug candidate to the clinic in 2 years.

AlzProtect will develop its candidates up to clinical phase 2a before licensing them to a Pharma partner for further development and marketing.

Our mission

We develop candidate drugs with a new therapeutic approach towards Alzheimer’s disease treatment until clinical Phase IIa